Shanghai Pharma(601607) 证券之星·2025-03-27 13:34Summary of Shanghai Pharmaceuticals Holding Co., Ltd. Audit Report Core Viewpoint The audit report details the non-operational fund occupation and other related fund transactions of Shanghai Pharmaceuticals Holding Co., Ltd., highlighting the financial interactions with its subsidiaries and associated parties. Group 1: Non-Operational Fund Occupation - The report indicates that there are no non-operational fund occupations from the current controlling shareholders or their affiliated enterprises [1] - The total non-operational fund occupation is summarized as not applicable for the listed company and its related parties [1] Group 2: Related Fund Transactions - The report lists various related fund transactions, including amounts and reasons for these transactions, with a total of 2,059,212.49 thousand yuan in initial transaction amounts [4] - Specific transactions include: - Shanghai Yingdalai Real Estate Co., Ltd. with a transaction amount of 492.71 thousand yuan for leasing income [1] - Shanghai Shishi Group Financial Services Co., Ltd. with a transaction amount of 416,604.36 thousand yuan, primarily for financial services [1] - Shanghai Pharmaceutical Holdings Co., Ltd. subsidiaries showing various amounts in non-operational fund transactions, such as 574,191.24 thousand yuan from Shanghai Keyuan Xinhai Medical Co., Ltd. [2][3] - The report also notes that the total amount of related fund transactions for the year 2024 is significant, with various subsidiaries involved in both operational and non-operational transactions [4]